Wanted: Physician Feedback on Medical Cannabis

Article

Medical marijuana information for mental health professionals

Question 1.

Click here for the next question

Question 2.

Click here for the next question

Question 3.

 

Click here for the next question

 Question 4.

Click here for the next question

Question 5.

 

Click here for the next question

Question 6.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
Duration of Use Guidance Published or Systemic Corticosteroids in Atopic Dermatitis Treatment / image credit Mark Lebwohl, MD Courtesy of Icahn School of Medicine, Mount Sinai

Duration of Use Guidance Published for Systemic Corticosteroids in Atopic Dermatitis Treatment

Grace Halsey
September 12th 2025
Article
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use

Sydney Jennings
September 12th 2025
Podcast
New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse / image credit FDA logo ©muhammed/stock.adobe.com

New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse

Grace Halsey
September 12th 2025
Article
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks

Sydney Jennings
September 12th 2025
Podcast
Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data Announced

Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data

Grace Halsey
September 12th 2025
Article
Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents

Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents

Sydney Jennings
September 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.